We report the national data on the outcomes of hematopoietic stem cell transplantation
(HSCT) for thalassemia major (TM) patients in Turkey on behalf of the Turkish Pediatric Stem …

In spite of advances in chelation therapy and screening of blood, mortality associated with
the most common life-threatening noncommunicable disease of children in India, transfusion …

Aim: To evaluate the outcome of children who underwent allogenic hematopoietic stem Cell
transplantation as a curative approach for Thalassemia Major, treated at Queen Rania AL …

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only established
curative therapy for thalassemia. However, access to transplantation is constrained in limited …

Background. Treating beta-thalassaemia major may entail high costs with considerable out-
of-pocket expenditure. Therefore, determination and valuation of the economic costs of a …

Numerous HLA allele relations with various diseases have been observed all over the
world, including leukemia, aplastic anemia, and thalassemia. The current study looked at the …

Background: Although the global thalassemia zone covers Bangladesh, there are very
limited studies conducted in this region. Therefore, the focus of our study is to understand …

Hematopoietic stem cell transplantation (HSCT) remains the only established definitive cure
for severe hemoglobinopathies, such as sickle cell disease (SCD) and thalassemia—the …

Results: The new sequential HLA-A, HLA-B, and HLA-DRB1 testing algorithm showed a
49.1% reduction in cost compared to the conventional HLA testing algorithm. Furthermore …

Introduction: Haematopoietic stem cell transplant (HSCT) is indicated for several disorders
as potentially curative treatment. However, establishing SCT unit demands infrastructure …